Eugene

[email protected]

LATEST

FDA Launches Pilot Program for Drug Supply-Chain Security
By

By
The US Food and Drug Administration (FDA) has launched a new pilot program as part of its implementation of the Drug Supply Chain Security Act (DSCSA), a federal law that…

Cerbios, Olon, PCI Expand; Thermo Fisher, GE in Biomfg Pacts
By

By
The latest news from contract development and manufacturing organizations, contract manufacturing organizations, and other suppliers featuring news from Cerbios-Pharma, Olon, Hovione, Thermo Fisher, GE Healthcare Life Sciences, and PCI Pharma…

J&J’s Janssen, MeiraGTx in $440-Million Gene-Therapy Product and Mfg Pact
By

By
Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has formed a worldwide collaboration and license agreement, worth up to $440 million, with MeiraGTx, a New York-…

Merck KGaA To Invest $70 Million in Massachusetts R&D Facility
By

By
Merck KGaA has announced a $70-million investment to expand its research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet and provide new laboratory…

Celgene, Triphase Accelerator in $980-Million Oncology Deal
By

By
Celgene and Triphase Accelerator, a Toronto based oncology-focused drug-development company, together with FACIT, Triphase’s majority shareholder and a collaboration partner for research companies and investors, have formed a strategic collaboration…

GSK, Merck KGaA Form $4.2-Billion Immuno-Oncology Deal
By

By
GlaxoSmithKline (GSK) and Merck KGaA have entered into a global strategic alliance, worth up to $4.2 billion, to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein…

Eli Lilly, AC Immune in $1.9-Billion Deal for Alzheimer’s Disease
By

By
Eli Lilly and Company and AC Immune SA, a Lausanne, Switzerland-based biopharmaceutical company, have formed an agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment…

Akorn CEO Retires; Court OKs Terminated Merger with Fresenius
By

By
Akorn, a Lake Forest, Illinois-headquartered specialty generic pharmaceutical company, has announced it will move forward as an independent company following a decision from the Supreme Court of the State of…

Cambrex, WuXi AppTec, Lonza Expand; Roquette Acquires Majority Stake in Excipient Manufacturer
By

By
A roundup of the latest news from suppliers, contract development and manufacturing organizations, and contract manufacturing organizations, featuring Cambrex, WuXi AppTec, Lonza, and Roquette. Chemicals/Chemical API Manufacturing Cambrex Expands Analytical…

FDA Issues Guidances To Advance Biosimilars Policy Framework
By

By
The US Food and Drug Administration (FDA) has released two guidances, one final and one draft, to advancie the agency’s biosimilars policy framework. The guidances describe the agency’s plan to…